Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient
Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
|---|---|
| Enthalten in: |
Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia - 39(2022), 3 vom: 14. Juni, Seite 357-360 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Neumonía por Pneumocystis jirovecii posterior a COVID-19 en un paciente sin infección por VIH |
|---|
| Beteiligte Personen: |
Amparo-Vicente, María [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 28.09.2022 Date Revised 28.09.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4067/s0716-10182022000200357 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346729548 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346729548 | ||
| 003 | DE-627 | ||
| 005 | 20231226032141.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.4067/s0716-10182022000200357 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1155.xml |
| 035 | |a (DE-627)NLM346729548 | ||
| 035 | |a (NLM)36156700 | ||
| 035 | |a (PII)S0716-10182022000300357 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Amparo-Vicente, María |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient |
| 246 | 3 | 3 | |a Neumonía por Pneumocystis jirovecii posterior a COVID-19 en un paciente sin infección por VIH |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.09.2022 | ||
| 500 | |a Date Revised 28.09.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 700 | 1 | |a Morte, Elena |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia |d 1997 |g 39(2022), 3 vom: 14. Juni, Seite 357-360 |w (DE-627)NLM092581005 |x 0717-6341 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:2022 |g number:3 |g day:14 |g month:06 |g pages:357-360 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4067/s0716-10182022000200357 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 2022 |e 3 |b 14 |c 06 |h 357-360 | ||